Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years. - Wikidata - wikimedia - TriplyDB

Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.

Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.

http://www.wikidata.org/entity/Q33600226

about

A computational linguistic measure of clustering behavior on semantic verbal fluency task predicts risk of future dementia in the nun study Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes.Population Normative Data for the CERAD Word List and Victoria Stroop Test in Younger- and Middle-Aged Adults: Cross-Sectional Analyses from the Framingham Heart Study.The common objects memory test (COMT): a simple test with cross-cultural applicability.CERAD practice effects and attrition bias in a dementia prevention trial Dementia Services Mini-Screen: a simple method to identify patients and caregivers in need of enhanced dementia care services.Monitoring cognitive functioning: psychometric properties of the brief test of adult cognition by telephone Neuropsychological Test Performance in Cognitively Normal Spanish-speaking Nonagenarians with Little Education.The epidemiology of mild cognitive impairment (MCI) and Alzheimer's disease (AD) in community-living seniors: protocol of the MemoVie cohort study, Luxembourg.Neuronal LR11 expression does not differentiate between clinically-defined Alzheimer's disease and control brains Heterogeneity in mild cognitive impairment: differences in neuropsychological profile and associated white matter lesion pathology CARDIOVASCULAR RISK FACTORS AFFECT HIPPOCAMPAL MICROVASCULATURE IN EARLY AD.Longitudinal associations between physical and cognitive performance among community-dwelling older adults.The relationship between brain-derived neurotrophic factor and cognitive functions in alcohol-dependent patients: a preliminary study Trajectory of Mobility Decline by Type of Dementia.Depressive Symptoms Affect Working Memory in Healthy Older Adult Hispanics.Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." A national registry to identify a cohort for Alzheimer's disease prevention studies.Age, gender, and education are associated with cognitive performance in an older Israeli sample with type 2 diabetes Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease.Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid.The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders.Finding of increased caudate nucleus in patients with Alzheimer's disease.Presenilin 2 deficiency facilitates Aβ-induced neuroinflammation and injury by upregulating P2X7 expression.Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.Intrinsic functional connectivity alterations in progressive supranuclear palsy: Differential effects in frontal cortex, motor, and midbrain networks.Alzheimer's disease with cerebrovascular disease: current status in the Asia-Pacific region.Prevalence of mild cognitive impairment and its subtypes in the Mexican population.Influence of pneumonia complications on the prognosis of patients with autopsy-confirmed Alzheimer's disease, dementia with Lewy bodies, and vascular dementia.APOE ε4 allele modifies the association of lead exposure with age-related cognitive decline in older individuals.The CERAD Neuropsychological Battery in Patients with Frontotemporal Lobar Degeneration Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.Extending XNAT Platform with an Incremental Semantic Framework MicroRNA-138 is a potential regulator of memory performance in humans.Detecting At-Risk Alzheimer's Disease Cases.Association between insulin and executive functioning in alcohol dependence: a pilot study.CERAD test performance and cognitive impairment in Parkinson's disease.Reliability of cognitive tests of ELSA-Brasil, the brazilian longitudinal study of adult health.Action of anti-TNF-α drugs on the progression of Alzheimer's disease: A case report.Person-Based Versus Generalized Impulsivity Disinhibition in Frontotemporal Dementia and Alzheimer Disease.High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.

P2860

Q28649523-DE17FFDD-14E8-4AFF-8F80-C8BD005942B7 Q30559371-C9F73DCA-B80F-487B-B5AF-CD473E23B605 Q31114398-9B31E52A-48A0-4394-B114-E2E0C618F468 Q33534921-CF94AB73-8746-4855-B020-81233AB1D317 Q33574782-54AAEEEF-0984-4DD3-9FD6-DA0D736DB143 Q33599933-541757FA-1EAA-4420-98CE-F1E8D6580F9A Q33728564-6526BEE9-B8DC-4BE3-B270-5DCEAA8E5496 Q33745505-AC97FED4-C98B-447B-9DBC-0BAF7E6D7082 Q34334180-1FFDEE84-3095-4438-B0F7-A27DD4C21DB2 Q34395343-BE8811B4-F4CB-4C98-9132-8932E885DB58 Q34556136-C302DA62-948F-4546-AE96-0122FF0321B7 Q34575537-5AAA6DEB-1216-48FD-8A26-F7D2044188F7 Q35393135-D46135B3-F9D7-4700-97E3-6C529A2B6F10 Q36088233-5FB99E67-7255-46FB-852D-D0CFC33B60DA Q36119206-A07107B6-BC00-41BF-8B29-BD01C2A38C48 Q36813111-0411B978-F0E4-4411-9A5B-68DEC3C8E819 Q37351643-770FC30E-8B46-41FB-8BDF-09D51D0DD721 Q37569360-86592966-4675-4EFB-A90E-4552CC2078BE Q37627051-FB242599-1357-4947-A524-CD3C01CCB643 Q38113683-5276B8F9-D96C-45A1-B79B-B1CDA0EC7000 Q38176151-162CC105-3C68-4B4C-8481-166DFDD2007D Q38662823-F1EDAC05-CB7D-41DA-9BFA-1C67F109A3B2 Q38719556-0783376C-A808-48C3-B8A3-B826E9347429 Q38725605-DC466E8C-8338-4FDF-94F4-77F3274345E9 Q38764036-CAE04351-B024-47AA-BE60-319771033F73 Q38780332-46205AE1-0D48-4D9D-850E-7C27E4EC79E2 Q40078301-8FD9A89F-BA06-473F-83A7-D6D94525F9BE Q40383156-D8D748F5-AED1-4886-812D-DFD1311E958D Q40533669-9048FA9D-A9D5-408C-B1B6-04BFC258DB4B Q40917984-1728D61E-8A63-4BF3-8958-12618E063738 Q41205194-F38D7DDA-07B0-466F-8758-EE7674A28A1F Q41606047-CB8CF9FE-9798-43A5-B7B6-E03FCE4A774B Q41845898-5D626CFB-AD7B-4915-ACF6-4D07C6284AF0 Q41863951-010E85CE-F6E4-43DA-835D-A220A96339AD Q42025769-ADDFD2C9-D7BE-4763-AA10-6EAD82A3ABB5 Q44998478-4EB8F3DE-DA10-48AB-82E0-AACDA6C2A09C Q45805665-423CA7DB-3345-4AC0-BA1F-B06DE9D88C61 Q46033935-76027FE1-3CBC-43CD-A2D9-959475527E6C Q46211395-84722933-F53E-401C-B846-976476D39DBD Q46216495-535C46A7-F99E-4B67-8C8F-A689FE0B3A1B

P2860

Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.

http://www.wikidata.org/entity/Q33600226

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Consortium to Establish a Regi ...... ERAD): the first twenty years.

@ast

Consortium to Establish a Regi ...... ERAD): the first twenty years.

@en

type

label

Consortium to Establish a Regi ...... ERAD): the first twenty years.

@ast

Consortium to Establish a Regi ...... ERAD): the first twenty years.

@en

prefLabel

Consortium to Establish a Regi ...... ERAD): the first twenty years.

@ast

Consortium to Establish a Regi ...... ERAD): the first twenty years.

@en

P1433

Q33600226-BEE85E03-895C-4470-B171-5647086F12A9

P1476

Q33600226-772902B5-7288-4FED-B2B5-36159408ABB5

P2093

Q33600226-068E2320-8F28-4732-BE53-0E81E61E0652

Q33600226-1FEB6203-C0E8-4F1F-AD8E-33483F3A1DA9

Q33600226-20CEFFBC-D737-4ADF-8D05-EE7A37920E57

Q33600226-2813CD5D-45C8-463D-B5E5-A37D61F50803

Q33600226-4B64DDE4-86C5-48D8-B046-EDBC24EDE2A7

Q33600226-5DD83740-A1B5-4121-8279-490F8CE8EB5F

Q33600226-620DCBD5-5CF3-486F-87B4-ECC8E88D86C9

Q33600226-6F78F1EB-6CC7-48C0-A44A-07BC38386B65

Q33600226-CA1EC66A-AB48-45EB-BDA4-CB51DE83903A

Q33600226-EB913782-BFA0-4544-93E9-0950413A573F

P2860

Q33600226-00E6AA53-E2A8-4723-8043-5D4691A8A75B

Q33600226-018455DB-2A0D-4A21-BD19-5E20AFF7DA57

Q33600226-0BF3E7DB-716A-43C5-AA7B-C34A1D7476BC

Q33600226-0EDA8FD0-9656-47D4-92D3-BDFB283D29FD

Q33600226-14293559-E8B2-410A-87D0-E0AC2E2D4915

Q33600226-1547B454-EE3C-40C4-BA26-1B93DDE76C89

Q33600226-15BC0680-93B7-4EE6-A163-F16207C5859E

Q33600226-16DCA901-AA26-4F9C-B101-D69A397F413E

Q33600226-1790502B-648B-45B6-9657-5759D31784B5

Q33600226-192DFB54-B8C4-4551-A7D4-C7B0D02EA76E

P304

Q33600226-F8994E17-1EF4-4D4B-B2B1-A5267FF546CC

P31

Q33600226-B795DD2D-F9B2-4870-9E95-27C8A072DE7C

P356

Q33600226-8DA4D670-D79D-4D99-929F-CC774B7469B3

P433

Q33600226-EA40B76C-C460-4733-90F3-D2716A480EAA

P478

Q33600226-C22CED5E-760A-4028-9D16-1379B277779E

P50

Q33600226-29F967DE-D245-4CA1-9074-631A3D14FBA2

P577

Q33600226-3D96896C-E616-49D7-AA1E-5C5F994045F5

P5875

Q33600226-1A80C071-F678-478E-9655-C5E0FDB4E794

P698

Q33600226-FC5CBADA-E049-40AE-B376-7B5FD0A6CCBC

P921

Q33600226-283E9415-679C-4EA9-9123-2CEE2B1334CA

P932

Q33600226-C1277342-CC1F-414D-B90E-4F9D3A376A6D

P356

J.JALZ.2007.08.005

P1433

Alzheimer's and Dementia

P1476

Consortium to Establish a Regi ...... ERAD): the first twenty years.

@en

P2093

Albert Heyman

http://www.w3.org/2001/XMLSchema#string

Christopher M Clark

http://www.w3.org/2001/XMLSchema#string

Gerald van Belle

http://www.w3.org/2001/XMLSchema#string

Gerda G Fillenbaum

http://www.w3.org/2001/XMLSchema#string

Jeremy M Silverman

http://www.w3.org/2001/XMLSchema#string

Kathleen A Welsh-Bohmer

http://www.w3.org/2001/XMLSchema#string

Patricia C Davis

http://www.w3.org/2001/XMLSchema#string

Pierre N Tariot

http://www.w3.org/2001/XMLSchema#string

Richard C Mohs

http://www.w3.org/2001/XMLSchema#string

Suzanne S Mirra

http://www.w3.org/2001/XMLSchema#string

P2860

Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Behavior Rating Scale for Dementia: development of test scales and presentation of data for 555 individuals with Alzheimer's disease.

The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

Cognitive function in UK community-dwelling African Caribbean elders: normative data for a test battery.

Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana.

P304

96-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JALZ.2007.08.005

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51406583

http://www.w3.org/2001/XMLSchema#string

P698

18631955

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2808763

http://www.w3.org/2001/XMLSchema#string